GWN Securities Inc. Acquires Shares of 642 UnitedHealth Group Incorporated (NYSE:UNH)

GWN Securities Inc. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 642 shares of the healthcare conglomerate’s stock, valued at approximately $341,000.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth about $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter worth about $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth about $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.5 %

Shares of NYSE UNH opened at $488.52 on Monday. The firm has a market cap of $446.85 billion, a price-to-earnings ratio of 31.52, a PEG ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business’s 50 day moving average is $511.36 and its two-hundred day moving average is $549.80.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.